Date post: | 22-Jan-2016 |
Category: |
Documents |
Upload: | sheldon-burnap |
View: | 213 times |
Download: | 0 times |
By Linda Self
Key Terms1.Ventilation2.Perfusion3.Diffusion4.Pulmonary Circulation5.Surfactant6.pneumocytes
Asthma—inflammation, hyperreactivity,
and bronchoconstriction GERD may cause
microaspiration/resultant nighttime cough
Antiasthma medications can also exacerbate GERD
May be triggered by viruses Irritants Allergens Can develop at any age Seen more often in children who are
exposed to airway irritants during infancy
Bronchoconstriction Inflammation Mucosal edema Excessive mucous
Mast cells Chemical mediators such as histamine,
prostaglandins, acetylcholine, cGMP, interleukins, leukotrienes are released when triggered. Mobilization of eosinophils. All cause movement of fluid and proteins into tissues.
Bronchoconstrictive substances antagonized by cAMP
Combination of chronic bronchitis and emphysema
Bronchoconstriction and inflammation are more constant, less reversibility
Anatomic and physiologic changes occur over years
Leads to increasing dyspnea and activity intolerance
Bronchodilators and anti-inflammatories
Step 1-Mild Intermittent—symptoms 2 days/week or less or 2 nights/month or less. No daily medication needed; treat with inhaled beta2 agonist
Step 2-Mild persistent—symptoms >2/week but <1x/day or >2 nights/month. In those >5 years old, use inhaled corticosteroid, leukotriene modifier, Intal (cromolyn), or sustained release theophylline
Step 2—Mild persistent Children 5 years and younger—inhaled
corticosteroid by nebulizer of MDI with a holding chamber. Can also use leukotriene modifier or Intal by nebulizer
Step 3—Moderate persistent. Symptoms daily and > one night per week.
Older than 5yo—low to med. Dose corticosteroid and long acting beta 2 agonist. Alternatives p. 714
Step 3— Children < 5 yo: low dose inhaled
corticosteroid and a long acting beta 2 agonist or medium dose inhaled corticosteroid
Step 4—Severe persistent—symptoms continual during daytime and frequently at night.
>5yo—high dose inhaled corticosteroid, long acting beta 2 agonist; intermittent admin. of oral corticosteroids
Step 4— Children less than 5 yo—same as for
adults and older children
Adrenergics—stimulate beta 2 receptors in smooth muscle of bronchi and bronchioles
Receptors stimulate cAMP =bronchodilation
Cardiac stimulation is an adverse effect of these medications
Cautious use in hypertension and cardiac disease
Selective beta 2 agonists by inhalation are drugs of choice
Epinephrine sc in acute bronchoconstriction
Proventil (albuterol) Xopenex (levalbuterol)
Treatment of first choice to relieve acute asthma
Aerosol or nebulization May be given by MDI Overuse will diminish their
bronchodilating effects>>>>tolerance
Foradil (formoterol) and Serevent (salmeterol) are long acting beta 2 adrenergic agonists used only for prophylaxis. Black box warning on Serevent—use in deteriorating asthma can be life-threatening
Alupent (metaproterenol)—intermediate acting. Useful in exercise induced asthma, tx acute bronchospasm.
Brethine (terbutaline)—selective beta 2 adrenergic agonist that is a long-acting bronchodilator
When given subq, loses selectivity Also used to decrease premature
uterine contractions during pregnancy
Block the action of acetylcholine in bronchial smooth muscle when given by inhalation
Action reduces intracellular guanosine monophosphate (GMP) which is a bronchoconstrictive substance
Atrovent (ipratropium)—caution in BPH, narrow-angle glaucoma
Spiriva (tiotropium)
Theophylline Mechanism of action unclear Bronchodilate, inhibit pulmonary
edema, increase action of cilia, strengthen diaphragmatic contractions, over-all anti-inflammatory action
Increases CO, causes peripheral vasodilation, mild diuresis, stimulates CNS
Contraindicated in acute gastritis and PUD
Second line Narrow therapeutic window—
therapeutic range is 5-15 mcg/mLh Multiple drug interactions
Suppress inflammation by inhibiting movement of fluid and protein into tissues; migration and function of neutrophils and eosinophils, synthesis of histamine in mast cells, and production of proinflammatory substances
Benefits: decreased mucous secretion, decreased edema and reduced reactivity
Second action is to increase the number and sensitivity of beta 2 adrenergic receptors
Can be given PO or IV Pulmonary function usually improves
within 6-8 hours Continue drugs for 7-10 days
Fewer long term side effects if inhaled
End-stage COPD may become steroid dependent
In asthma, systemic steroids generally are used only temporarily
Taper high dose oral steroids to avoid hypothalamic-pituitary axis suppression
For inhalation: Beclovent—beclomethasone Pulmicor—budesonide Aerobid—flunisolide Flovent—fluticasone Azmacort—triamcinolone Most inhaled steroids are being
reformulated with HFA
Systemic use: prednisone, methylprednisolone, and hydrocortisone
In acute, severe asthma—a systemic corticosteroid may be indicated when inhaled beta 2 agonists are ineffective
Leukotrienes are strong chemical mediators of bronchoconstriction and inflammation
Increase mucous secretion and mucosal edema
Formed by the lipoxygenase pathway of arachidonic acid metabolism in response to cellular injury
Are release more slowly than histamine
Developed to counteract the effects of leukotrienes
Indicated for long term treatment of asthma in adults and children
Prevent attacks induced by some allergens, exercise, cold air, hyperventilation, irritants and ASA/NSAIDs
Not useful in acute attacks
Injured cell
Arachidonic acid XXXX Lipooxygenase
Leukotrienes XXXX Bronchi, WBCs
Bronchoconstriction
Singulair (montelukast) and Accolate (zafirlukast) are leukotriene receptor antagonists
Can be used in combination with bronchodilators and corticosteroids
Less effective than low doses of inhaled steroids
Should not be used during lactation Can cause HA, nausea, diarrhea, other
Intal (cromolyn) Tilade (nedocromil) Prevent release of bronchoconstrictive
and inflammatory substances when mast cells are confronted with allergens and other stimuli
Prophylaxis only Inhalation, nebulizer or MDI, nasal
spray as well
Xolair (omalizumab) works by binding to IgE, blocking receptors on surfaces of mast cells and basophils
Prevents release of chemical mediators of allergic reactions
Adjunctive therapy Can cause life-threatening
anaphylaxis
Histamine is the first chemical mediator released in immune and inflammatory responses
Concentrated in skin, mucosal surfaces of eyes, nose, lungs, CNS and GI tract
Located in mast cells and basophils Interacts with histamine receptors on
target organs called H1 and H2
H1 receptors are located mainly on smooth muscle cells in blood vessels and the respiratory and GI tracts
H1 binding causes: pruritus, flushing, increased mucous production, increased permeability of veins—edema, contraction of smooth muscle in bronchi>>bronchoconstriction and cough
With H2 receptor stimulation, main effects are increased secretion of gastric acid and pepsin, decreased immunologic and proinflammatory reactions, increased rate and force of myocardial contraction
Are exaggerated responses by the immune sysem that produce tissue injury and possible serious disease
Allergic reactions may result from specific antibodies, sensitized T lymphocytes, or both, formed durng exposure to an antigen.
Type I—immediate hypersensitivity, IgE induced response triggered by the interaction of antigen with antigen-specific IgE bound on mast cells
Anaphylaxis is an example Does not occur on first exposure to
an antigen Can develop profound vasodilation
resulting in hypotension, laryngeal edema, bronchoconstriction
Type II—IgG or IgM mediated which generate direct damage to cell surfaces. Examples include: blood transfusion reactions, hemolytic disease of newborns, hypersensitivity reactions to drugs such as heparin or penicillin
Type III is an IgG or IgM mediated reaction characterized by formation of antigen-antibody complexes that induce inflammatory reaction in tissues. Prototype is Serum Sickness.
Immune response can occur following antitoxin administration, pcn or sulfa drugs
Delayed hypersensitivity Cell mediated response where
sensitized T lymphocytes react with an antigen to cause inflammation, release of lymphokines , direct cytotoxicity or both
Classic examples are tuberculin test, contact dermatitis and some graft rejections
IgE mediated Inflammation of nasal mucosa caused
by a hypersensitivity reaction to inhaled allergens
Presents with itching of throat, eyes and ears
Seasonal and perennial Can lead to chronic fatigue, difficulty
sleeping, sinus infections, postnasal drip, cough and headache
Atrovent nasal spray Beconase (beclomethasone) Rhinocort (budesonide) Flonase (fluticasone) Nasonex (mometasone) Nasalcrom (a mast cell stabilizer)
Type IV hypersensitivity reaction Poison ivy an example Usually occurs >24h after re-
exposure
Allergic food reactions—result from ingestion of a protein
Most common food allergy is shellfish, others include milk, eggs, peanuts
Allergic drug reactions—unpredictable, may occur 7-10 days after initial exposure
Pseudoallergic drug reactions—resemble immune responses but do not produce antibodies, i.e. anaphylactoid
Inhibit smooth muscle constriction in blood vessels and the respiratory and GI tracts
Decrease capillary permeability Decrease salivation and tear
formation Act by binding with the histamine
receptor
Allergic rhinitis Anaphylaxis Allergic conjunctivitis Drug allergies Transfusions of blood products Dermatologic conditions Nonallergic such as motion sickness,
nausea and vomiting, sleep
Caution in pregnancy BPH Bladder neck obstruction Narrow angle glaucoma
Bind to central and peripheral receptors Can cause CNS depression or stimulation Have substantial anticholinergic effectsExamples: Chlor-Trimeton (chlorpheniramine) Benadryl (diphenhydramine) Vistaril (hydroxyzine) Phenergan (promethazine)
Selective or nonsedating Do not cross blood brain barrierExamples: Astelin (azelastine) Allegra (fexofenadine) Claritin (loratadine) Clarinex (desloratadine) Zyrtec Xyzal
Relieve nasal obstruction and discharge Adrenergic Rebound nasal swelling called “rhinitis
medicamentosa” Afrin Sudafed (pseudoephedrine) Contraindicated in severe
hypertension, CAD, narrow angle glaucoma, TCAs or MAOIs
Suppress cough by depressing cough center in medulla or by increasing flow of saliva
For dry, hacking, non-productive cough
Not recommended in children and adolescents
Codeine, hydrocodone dextromethorphan
Liquefy respiratory secretions Guiafenesin
By inhalation to liquefy mucous Mucomyst (acetylcysteine) May be used in treating
acetaminophen overdose
Contain antihistamine, decongestant and an analgesic
Chlorpheniramine, pseudoephedrine, acetaminophen, dextromethorphan and guiafenesin
Decongestants can cause stasis of secretions
PM contains antihistamine Tamiflu can be used to limit spread of
virus in respiratory tract
1. Name two beta adrenergic bronchodilators
2. Name an inhaled steroid3. Give an example of a leukotriene modifier4. Name a mast cell stabilizer5. Name a common infection after frequent
use of an inhaled steroid6. Name a first generation H1 receptor
antagonist
7. Name a second generation H1 receptor antagonist.
8. Name an H2 receptor antagonist.